4.4 Article

Inhaled nitric oxide use in neonates: Balancing what is evidence-based and what is physiologically sound

Journal

NITRIC OXIDE-BIOLOGY AND CHEMISTRY
Volume 95, Issue -, Pages 12-16

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.niox.2019.12.001

Keywords

Nitric oxide; Persistent pulmonary hypertension of the newborn; Pulmonary arterial hypertension; Neonate; Respiratory failure; Bronchopulmonary dysplasia

Funding

  1. NIH [R01HL132941, K08 HL132014-01]

Ask authors/readers for more resources

Inhaled nitric oxide is a powerful therapeutic used in neonatology. Its use is evidenced-based for term and near-term infants with persistent pulmonary hypertension; however, it is frequently used off-label both in term and preterm babies. This article reviews the off-label uses of iNO in infants. Rationale is discussed for a selective application of iNO based on physiologically guided principles, and new research avenues are considered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available